| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO | /s/ T.O. Odutayo, Attorney-in-Fact for Nicholas J. Donoghoe | 07 Aug 2025 | 0001762951 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABBV | Common Stock, $0.01 par value | Sale | -$641K | -3.23K | -4.52% | $198.27 | 68.3K | 05 Aug 2025 | Direct | F1, F2 |
| transaction | ABBV | Common Stock, $0.01 par value | Sale | -$2M | -10.1K | -14.73% | $198.59 | 58.2K | 05 Aug 2025 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.26 to $198.37 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | This reflects shares acquired pursuant to a dividend reinvestment plan. |
| F3 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.56 to $198.73 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |